Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;41(1):120-7.
doi: 10.1016/j.ejso.2014.09.007. Epub 2014 Oct 7.

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis

D P Al-Adra  1 , R S Gill  1 , S J Axford  2 , X Shi  3 , N Kneteman  1 , S-S Liau  4
Affiliations

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis

D P Al-Adra et al. Eur J Surg Oncol. 2015 Jan.

Abstract

Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic cholangiocarcinoma (ICC). However, the rarity and heterogeneity of ICC makes it difficult to draw firm conclusions about treatment efficacy. Therefore, the goal of the current study is to systematically review the existing literature surrounding treatment of unresectable ICCs with yttrium-90 microspheres and provide a comprehensive review of the current experience and clinical outcome of this treatment modality. We performed a comprehensive search of electronic databases for ICC treatment and identified 12 studies with relevant data regarding radioembolization therapy with yttrium-90 microspheres. Based on pooled analysis, the overall weighted median survival was 15.5 months. Tumour response based on radiological studies demonstrated a partial response in 28% and stable disease in 54% of patients at three months. Seven patients were able to be downstaged to surgical resection. The complication profile of radioembolization is similar to that of other intra-arterial treatment modalities. Overall survival of patients with ICC after treatment with yttrium-90 microspheres is higher than historical survival rates and shows similar survival to those patients treated with systemic chemotherapy and/or trans-arterial chemoembolization therapy. Therefore, the use of yttrium-90 microspheres should be considered in the list of available treatment options for ICC. However, future randomized trials comparing systemic chemotherapy, TACE and local radiation will be required to identify the optimal treatment modality for unresectable ICC.

Keywords: Cholangiocarcinoma; Radioembolization; Yttrium-90 microsphere.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flow diagram showing selection of articles for review.
See this image and copyright information in PMC

References

    1. Shaib Y.H., Davila J.A., McGlynn K., El-Serag H.B. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar;40(3):472–477. - PubMed
    1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001 Jun;33(6):1353–1357. - PubMed
    1. Jemal A., Murray T., Ward E. Cancer statistics, 2005. CA Cancer J Clin. 2005 Jan–Feb;55(1):10–30. - PubMed
    1. Poultsides G.A., Zhu A.X., Choti M.A., Pawlik T.M. Intrahepatic cholangiocarcinoma. Surg Clin North Am. 2010 Aug;90(4):817–837. - PubMed
    1. Tan J.C., Coburn N.G., Baxter N.N., Kiss A., Law C.H. Surgical management of intrahepatic cholangiocarcinoma–a population-based study. Ann Surg Oncol. 2008 Feb;15(2):600–608. - PubMed

Publication types